My affected person wanted a fecal transplant after a dental an infection

Just lately, a brand new affected person walked into my apply indignant, not at me, however at his earlier dentist. This is the irony: his normal dentist did nothing incorrect. The dentist appropriately identified a dental abscess and appropriately referred the affected person to an endodontist. The endodontist, following what many take into account normal protocol again within the day, prescribed clindamycin. What occurred subsequent remodeled a dental an infection right into a medical nightmare that would have been averted.

The affected person developed extreme watery diarrhea inside days. He ended up hospitalized for IV fluids and obtained a analysis of Clostridioides difficile an infection, generally generally known as C. diff. Two rounds of antibiotics adopted. Then got here the recurrences—not one, however a number of episodes. Ultimately, he confronted a alternative that no affected person ought to need to make: proceed struggling by limitless cycles of an infection or endure fecal microbiota transplantation.

Understanding C. Diff: Past the textbook definition

We have all heard the time period C. diff talked about in dental faculty and persevering with schooling programs. However do you actually perceive the complete cascade of struggling this an infection unleashes, notably the end-stage therapy? Whereas I used to be conversant in fecal microbiota transplantation, or FMT, I had by no means met a affected person who truly underwent the process.

Clostridioides difficile is an opportunistic pathogen lurking in roughly 0-15% of wholesome adults’ colons,¹ held in verify by a various ecosystem of useful micro organism. When antibiotics decimate this protecting flora, C. diff seizes the chance. The micro organism produce toxins: TcdA and TcdB, that assault the intestinal lining, inflicting irritation and injury starting from uncomfortable to life-threatening.²

The preliminary signs appear manageable sufficient: watery diarrhea, belly cramping, fever.³ However C. diff would not play by gentle guidelines. The an infection can progress to pseudomembranous colitis, the place the colon develops inflammatory plaques seen on colonoscopy. In extreme circumstances, sufferers develop poisonous megacolon—a medical emergency the place the colon dilates dangerously and might perforate.

C. difficile an infection carries important mortality. A big US surveillance research discovered that C. diff was accountable for roughly half one million infections and 29,000 deaths in a single yr.⁴ Older adults are at notably excessive threat for extreme outcomes.

This is what makes C. diff notably insidious: recurrence.⁵ After therapy of an preliminary C. difficile an infection, roughly 20%–30% of sufferers expertise recurrence. With every subsequent episode, the chance of recurrence will increase considerably, typically reaching 40%–60%. Every recurrence turns into tougher to deal with, making a vicious cycle that devastates sufferers’ high quality of life.

Whereas any antibiotic can set off C. diff by disrupting intestine flora, sure lessons pose dramatically increased dangers. Clindamycin sits on the prime of that harmful record. Research display that clindamycin use will increase C. diff threat by 17-fold elevated odds in comparison with nonuse.⁶ Learn that once more: 17 occasions increased threat. This is not a marginal improve; it is an astronomical elevation that persists for months after even a brief course of remedy.

The mechanism is easy however might be devastating. Clindamycin excels at killing anaerobic micro organism.⁷ Sadly, it could additionally considerably disrupt the useful anaerobic micro organism within the colon. This disruption reduces colonization resistance, creating situations that enable C. difficile to proliferate. The drug’s broad spectrum turns into its legal responsibility, creating precisely the situations that enable this opportunistic pathogen to flourish.

The therapy that sufferers cannot overlook

My new affected person’s C. diff infections turned recurrent and refractory to straightforward antibiotic remedy. This left one remaining possibility: fecal microbiota transplantation, or FMT. Whereas remedy charges exceed 90%,⁸ genuinely spectacular in medication, the psychological burden is substantial.

In 2023, the FDA permitted Vowst, an oral model of FMT.⁹ As an alternative of receiving donor stool through colonoscopy or enema, sufferers now swallow oral capsules. However make no mistake: sufferers know precisely what they’re ingesting. These capsules comprise fecal microbiota from rigorously screened donors, processed and freeze-dried, however unmistakably human stool. Regardless of intensive screening protocols, there stays a small likelihood that not all viruses might be utterly eliminated. The capsules are designed to revive the varied bacterial ecosystem that forestalls C. diff colonization, a noble function that does not erase the psychological weight of the therapy.

My affected person described the expertise as humiliating and traumatic. He took 4 capsules day by day for 3 consecutive days, every dose a stark reminder of how a routine dental antibiotic had derailed his well being. The bodily restoration took weeks. The psychological scars will probably final years, as they actually would for me.

The options we should always have chosen first

Even for sufferers with documented penicillin allergic reactions, safer options exist.¹⁰ Azithromycin, a macrolide antibiotic, supplies wonderful protection towards gram-positive aerobes together with Streptococcus species generally implicated in dental infections.

Whereas macrolides provide restricted anaerobic protection, combining azithromycin with metronidazole creates complete antimicrobial protection for odontogenic infections with dramatically decrease C. diff threat. Metronidazole successfully targets gram-positive and gram-negative anaerobes together with Prevotella and Porphyromonas species.

Really helpful routine for penicillin-allergic sufferers:

• Azithromycin: 500 mg on day 1, then 250 mg day by day on days 2-4
• Metronidazole: 500 mg 3 times day by day for 7 days

For sufferers with out penicillin allergic reactions, amoxicillin and amoxicillin-clavulanate stay protected, efficient first-line choices with considerably decrease C. diff threat profiles.

What this implies to your apply

The dental neighborhood should embrace antibiotic stewardship not as a bureaucratic burden however as basic affected person care.

Earlier than you write the subsequent prescription, ask your self: Is that this actually your best option, or just the routine one? Have I thought-about safer options? Does this remedy have drug interactions with the affected person’s current drugs?

Most of us do not have refined medical resolution help software program that flags high-risk prescribing patterns. However instruments exist: packages like MedAssent DDS provide real-time warnings about problematic antibiotic decisions and recommend evidence-based options with dosing steering. Your entire course of takes lower than one minute … one minute to doubtlessly spare a affected person months of struggling.

The underside line

Our prescription pads and e-prescribing wield great energy over sufferers’ lives. Each antibiotic we prescribe ripples by their microbiome, their immune system, and their general well being. We should wield this energy with higher knowledge, at all times preserving in thoughts: First, do no hurt.

The selection is yours. Select correctly.

Additionally by the writer:

References

1. Furuya-Kanamori L, Marquess J, Yakob L, et al. Asymptomatic Clostridium difficile colonization: epidemiology and medical implications. BMC Infect Dis. 2015;15:516. doi:1186/s12879-015-1258-4
2. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of motion and function in illness. Clin Microbiol Rev. 2005;18(2):247-263. doi:10.1128/CMR.18.2.247-263.2005
3. Mada PK, Alam MU. Clostridioides difficile An infection. StatPearls [Internet]. StatPearls Publishing; 2026. https://www.ncbi.nlm.nih.gov/books/NBK431054/
4. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile an infection in the USA. N Engl J Med. 2015;372(9):825-834. doi:1056/NEJMoa1408913
5. Administration of recurrent Clostridioides difficile an infection and use of fecal microbiota transplantation in the course of the COVID-19 pandemic. Mayo Clinic. February 5, 2021. https://www.mayoclinic.org/medical-professionals/digestive-diseases/information/management-of-recurrent-clostridioides-difficile-infection-and-use-of-fecal-microbiota-transplantation-during-the-covid-19-pandemic/mac-20507272
6. Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the chance of community-associated Clostridium difficile an infection. Antimicrob Brokers Chemother. 2013;57(5):2326-2332. doi:10.1128/AAC.02176-12
7. Vincent C. Manges AR. Antimicrobial use, human intestine microbiota and Clostridium difficile colonization and an infection. Antiobiotics (Basel). 2015;4(3):230-253. doi:3390/antibiotics4030230
8. Baunwall SMD, Lee MM, Eriksen MK, et al. Faecal microbiota transplantation for recurrent Clostridioides difficile an infection: an up to date systematic assessment and meta-analysis. eClinicalMedicine. 2020;29-30:100642. doi:1016/j.eclinm.2020.100642
9. FDA approves first orally administered fecal microbiota product for the prevention of recurrence of Clostridioides difficile Press launch. U.S. Meals & Drug Administration. April 26, 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-first-orally-administered-fecal-microbiota-product-prevention-recurrence-clostridioides
10. Safar J. Overview of dental emergencies. Merck Guide. Revised November 2024. https://www.merckmanuals.com/skilled/dental-disorders/dental-emergencies/overview-of-dental-emergencies